← ANALYST RATINGS · TIPRANKS
Metlife (MET): analyst forecast and price target
Analyst consensus
Strong Buy10 Buy1 Hold0 Sell
Ratings of 11 analysts in the last 3 months · top analysts only12-month forecast
Based on 11 price targets given in the last 3 months, the average target is $111, the highest $119, the lowest $108. The average is +10.4% from the last price of $101.
Analyst ratings 14
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Pablo Singzon★★★★★★★★★★#2864 · hits 60% · avg +9.5% | J.P. Morgan | $108 → $110+1.9% | Buy | +9.2% | Assigned | 15.10.26on TipRanks 07:40 | +0.3%next day +1.6% | ↗ |
| Wesley Carmichael★★★★★★★★★★#2704 · hits 73% · avg +17.5% | Wells Fargo | $109 → $110+0.9% | Buy | +9.2% | Reiterated | 12.10.26on TipRanks 08:50 | +1.9%next day +0.5% | ↗ |
| Paul Newsome★★★★★★★★★★#122 · hits 73% · avg +13.9% | Piper Sandler | $110 | Buy | +9.2% | Reiterated | 12.10.26on TipRanks 06:55 | +1.9%next day +0.5% | ↗ |
| Joshua Shanker★★★★★★★★★★#1027 · hits 61% · avg +7.2% | Bank of America Securities | $119 | Buy | +18.1% | Reiterated | 12.10.26on TipRanks 06:15 | +1.9%next day +0.5% | ↗ |
| Ryan Krueger★★★★★★★★★★#560 · hits 72% · avg +13.6% | KBW | $108 | Buy | +7.2% | Reiterated | 08.10.26on TipRanks 16:50 | −0.7%next day +1.9% · 5 days +4.4% | ↗ |
| Yaron Kinar★★★★★★★★★★#401 · hits 72% · avg +12.2% | Mizuho Securities | $112 → $109−2.7% | Buy | +8.2% | Reiterated | 07.10.26on TipRanks 07:20 | −1.2%next day +3.2% · 5 days +5.1% | ↗ |
| Alex Scott★★★★★★★★★★#1272 · hits 60% · avg +7.0% | Barclays | $97.00 → $111+14.4% | Buy | +10.2% | Reiterated | 07.10.26on TipRanks 03:55 | −1.2%next day +3.2% · 5 days +5.1% | ↗ |
| Michael Ward CFA★★★★★★★★★★#1129 · hits 71% · avg +13.8% | UBS | $105 → $110+4.8% | Buy | +9.2% | Reiterated | 06.10.26on TipRanks 07:35 | −0.3%next day −1.2% · 5 days +3.7% | ↗ |
| Bob Huang★★★★★★★★★★#6914 · hits 57% · avg +0.4% | Morgan Stanley | $111 | Buy | +10.2% | Assigned | 05.10.26on TipRanks 08:35 | +1.9%next day −0.3% · 5 days +3.0% | ↗ |
| Andrew Kligerman★★★★★★★★★★#731 · hits 68% · avg +11.3% | TD Cowen | $105 → $110+4.8% | Buy | +9.2% | Assigned | 05.10.26on TipRanks 07:31 | +1.9%next day −0.3% · 5 days +3.0% | ↗ |
| Suneet Kamath★★★★★★★★★★#644 · hits 68% · avg +10.5% | Jefferies | $103 → $115+11.7% | Buy | +14.1% | Reiterated | 01.10.26on TipRanks 10:25 | 0.0%next day −0.7% · 5 days +3.1% | ↗ |
| Wilma Burdis★★★★★★★★★★#2846 · hits 77% · avg +10.4% | Raymond James | — | Hold | — | Reiterated | 29.09.26on TipRanks 09:11 | −0.5%next day −0.9% · 5 days +0.1% | ↗ |
| AI PerPlexity Insurance - LifePerPlexity SonarPro | TipRanks - PerPlexity | $112 → $110−1.8% | Buy | +9.2% | Reiterated | 20.08.26on TipRanks Aug 19 23:06 | — | |
| AI Google Insurance - LifeGemini 3.1Pro | TipRanks - Google | $115 → $111−3.5% | Buy | +10.2% | Reiterated | 18.08.26on TipRanks Aug 17 22:05 | — | |
| AI xAi Insurance - LifexAI Grok-4 | TipRanks - xAI | $114 → $111−2.6% | Buy | +10.2% | Reiterated | 18.08.26on TipRanks Aug 17 22:05 | — | |
| AI Anthropic Insurance - LifeAnthropic Opus-4.6 | TipRanks - Anthropic | $106 → $104−1.9% | Hold | +3.2% | Reiterated | 18.08.26on TipRanks Aug 17 22:05 | — | |
| AI DeepSeek Insurance - LifeDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $113 → $110−2.7% | Buy | +9.2% | Reiterated | 18.08.26on TipRanks Aug 17 22:05 | — | |
| AI OpenAI Insurance - LifeOpenAI 5.2 | TipRanks - OpenAI | $113 → $112−0.9% | Buy | +11.2% | Reiterated | 18.08.26on TipRanks Aug 17 22:05 | — | |
| Thomas Gallagher★★★★★★★★★★#2492 · hits 61% · avg +7.2% | Evercore ISI | $95.00 → $96.00+1.1% | Hold | −4.7% | Reiterated | 09.04.26on TipRanks 08:40 | −0.2%next day −1.0% · 5 days +0.1% | ↗ |
| Kevin Heal★★★★★★★★★★#879 · hits 74% · avg +12.6% | Argus Research | $90.00 | Buy | −10.7% | Reiterated | 08.12.25on TipRanks Dec 9 10:00 | −0.4%next day −0.2% · 5 days +6.2% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Metlife
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $109 at a price of $94.16 (+15.8%); now: $111 at $101 (+10.3%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 16 | 13 | 17 | 17 | 18 | 19 |
| Hold | 5 | 6 | 4 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 04.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $2.76 (from $2.55 to $2.91). Last quarter: $2.43.
Sales
Next quarter’s sales estimate — $19.9B (from $19.2B to $20.6B). Last quarter: $19.3B.
Best top-analyst consensus in the sector · Financial
About Metlife
- CEO: Michel Abbas Khalaf
- Employees: 46,000
- 200 Park Avenue, New York City, NY, 10166-0188, US
- www.metlife.com
MetLife, Inc. operates as a leading global financial services entity, delivering an extensive array of services encompassing insurance, annuities, employee benefits, and asset management. The company manages its operations through five primary divisions: the U.S., Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings. Its broad insurance offerings include life, dental, group short-term and long-term disability, individual disability, pet, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans. MetLife also supports employers with administrative services-only (ASO) arrangements. Furthermore, it provides sophisticated financial instruments such as general and separate account contracts, synthetic guaranteed interest contracts, and private floating rate funding agreements. The company facilitates pension risk transfers, offers institutional income annuities, structures settlements, and delivers capital markets investment products. Specialized life insurance products and funding agreements are also available for post-retirement benefits, alongside company, bank, or trust-owned life insurance used to finance non-qualified executive benefit programs. In addition, MetLife offers a variety of annuity options including fixed, indexed-linked, and variable, alongside pension and regular savings products. Its life insurance portfolio features whole life, term life, endowments, universal and variable life, and group life policies. The company also provides longevity reinsurance solutions, credit insurance products, and protection for long-term healthcare services. MetLife, Inc. was founded in 1863 and is headquartered in New York City.
Data from the stock’s TipRanks forecast page, read 33 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗